Quality and Safety

The J&J scientists said that out of 75,000 participants in a clinical trial, there was just one case of cerebral venous sinus thrombosis.

The impact of COVID-19 is felt most severely in communities of color, yet the disparities have not been the result of the pandemic.

This week's top stories include the CDC and FDA pausing the use of the Johnson & Johnson vaccine and the Mayo Clinic launching a platform that delivers advanced, AI-powered clinical decision support through remote monitoring.

Even with temporary hold on third vaccine, there is enough of a supply of Moderna and Pfizer to vaccinate every American, Biden says.

Dr. David Danhauer, CMIO of Owensboro Health, describes a safety initiative he devised that helps review and track clinical notes to ensure radiology reports are capturing incidental findings that could impact patient outcomes.

The pandemic has acted as an accelerant for the development and evolution of these technologies.

Healthcare provider organizations operating multiple EHR systems face a number of hurdles, says Justin Diehl, VP of Epic services at CereCore, who offers best practices to jump those hurdles.

The goal of the partnership is to enhance care by enabling members to receive certain healthcare services in their homes.

All six cases occurred among women between the ages of 18 and 48, and symptoms occurred six to 13 days after vaccination.

Many beneficiaries with end-stage kidney disease suffer from poor health outcomes and face increased risk of complications.